Related Experiment Video
Updated: Sep 27, 2026

In Vivo Mouse Model of Spinal Implant Infection
Published on: June 23, 2020
Linezolid: implications for neurosurgical infections
Cindy M Nguyen1, Lisa L Larive, Denise H Rhoney
1Wayne State University College of Pharmacy and Allied Health Professions, Detroit, MI, USA.
Abstract:
Nosocomial infections affect a significant number of intensive care unit (ICU) patients including those in the neurosurgical ICU. Gram-positive organisms are responsible for many of these infections and often these pathogens are resistant to some of the older antimicrobial agents. Two new classes of antibiotics have been developed: streptogramins and oxazolidinones. Linezolid is an oxazolidinone, which has been shown to be effective against methicillin- and vancomycin-resistant Gram-positive pathogens. It may be administered orally or parenterally, and displays favorable pharmacokinetic properties, with rapid and complete absorption after oral administration. Linezolid is generally well tolerated with mild gastrointestinal related adverse effects. Linezolid provides a useful alternative in the treatment of Gram-positive infections, particularly those caused by resistant organisms. It has tremendous clinical utility, especially in the ICU where infections and multi-drug resistant rates are high and treatment options become limited.
Insights
Linezolid, an oxazolidinone antibiotic, effectively treats Gram-positive infections, including those resistant to older drugs. It offers a valuable option for intensive care units (ICUs) facing high rates of multi-drug resistant pathogens.
Area of Science:
- Infectious Diseases
- Pharmacology
- Critical Care Medicine
Background:
- Nosocomial infections are common in intensive care units (ICUs), particularly neurosurgical ICUs.
- Gram-positive organisms frequently cause these infections and often exhibit resistance to traditional antibiotics.
- Emerging antibiotic classes like oxazolidinones offer new treatment avenues.
Purpose of the Study:
- To evaluate the efficacy and utility of linezolid, an oxazolidinone antibiotic, in treating Gram-positive nosocomial infections.
- To highlight linezolid's role in managing infections caused by multi-drug resistant pathogens in critical care settings.
Main Methods:
- Review of existing literature on linezolid's effectiveness against resistant Gram-positive pathogens.
- Assessment of linezolid's pharmacokinetic properties, including oral and parenteral administration.
- Evaluation of linezolid's safety profile and adverse effects.
Main Results:
- Linezolid demonstrates efficacy against methicillin-resistant and vancomycin-resistant Gram-positive pathogens.
- It exhibits favorable pharmacokinetics with rapid and complete oral absorption.
- Generally well-tolerated, with mild gastrointestinal side effects reported.
Conclusions:
- Linezolid is a valuable alternative for treating Gram-positive infections, especially those caused by resistant organisms.
- Its clinical utility is significant in ICUs with high rates of multi-drug resistant infections and limited treatment options.
Related Concept Videos
Brain Abscess l: Introduction
Cryptococcal Meningitis
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Local Anesthetics: Clinical Application as Spinal Anesthesia
Acute Pyelonephritis II: Diagnostic Studies and Management
Bacterial Meningitis I: Introduction